Global Sorafenib Industry Research Report 2020, Forecast to 2025

June 2020 | 108 pages | ID: G6E9F83B72F1EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Sorafenib market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Sorafenib is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Sorafenib industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Sorafenib by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Sorafenib market are discussed.

The market is segmented by types:

• Patented Drugs
• Generic Drugs

It can be also divided by applications:

• Kidney Cancer
• Liver Cancer
• Thyroid Cancer
• Other

And this report covers the historical situation, present status and the future prospects of the global Sorafenib market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Bayer
• Mylan
• Natco Pharma
• Cipla

Report Includes:

• xx data tables and xx additional tables
• An overview of global Sorafenib market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Sorafenib market
• Profiles of major players in the industry, including Bayer, Mylan, Natco Pharma, Cipla, .....

Research objectives

• To study and analyze the global Sorafenib consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Sorafenib market by identifying its various subsegments.
• Focuses on the key global Sorafenib manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Sorafenib with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Sorafenib submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Sorafenib Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Sorafenib Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 SORAFENIB INDUSTRY OVERVIEW

2.1 Global Sorafenib Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Sorafenib Global Import Market Analysis
  2.1.2 Sorafenib Global Export Market Analysis
  2.1.3 Sorafenib Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Patented Drugs
  2.2.2 Generic Drugs
2.3 Market Analysis by Application
  2.3.1 Kidney Cancer
  2.3.2 Liver Cancer
  2.3.3 Thyroid Cancer
  2.3.4 Other
2.4 Global Sorafenib Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Sorafenib Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Sorafenib Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Sorafenib Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Sorafenib Manufacturer Market Share
  2.4.5 Top 10 Sorafenib Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Sorafenib Market
  2.4.7 Key Manufacturers Sorafenib Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Sorafenib Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Sorafenib Industry Impact
  2.7.1 How the Covid-19 is Affecting the Sorafenib Industry
  2.7.2 Sorafenib Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Sorafenib Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Sorafenib Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL SORAFENIB MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Sorafenib Sales Market Share by Region
4.2 Global Sorafenib Revenue Market Share by Region (2015-2019)
4.3 Global Sorafenib Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Sorafenib Market Size Detail
  4.4.1 North America Sorafenib Sales Growth Rate (2015-2020)
  4.4.2 North America Sorafenib Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Sorafenib Market Size Detail
  4.5.1 Europe Sorafenib Sales Growth Rate (2015-2020)
  4.5.2 Europe Sorafenib Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Sorafenib Market Size Detail
  4.6.1 Japan Sorafenib Sales Growth Rate (2015-2020)
  4.6.2 Japan Sorafenib Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Sorafenib Market Size Detail
  4.7.1 China Sorafenib Sales Growth Rate (2015-2020)
  4.7.2 China Sorafenib Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL SORAFENIB MARKET SEGMENT BY TYPE

5.1 Global Sorafenib Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Sorafenib Sales and Market Share by Type (2015-2020)
  5.1.2 Global Sorafenib Revenue and Market Share by Type (2015-2020)
5.2 Patented Drugs Sales Growth Rate and Price
  5.2.1 Global Patented Drugs Sales Growth Rate (2015-2020)
  5.2.2 Global Patented Drugs Price (2015-2020)
5.3 Generic Drugs Sales Growth Rate and Price
  5.3.1 Global Generic Drugs Sales Growth Rate (2015-2020)
  5.3.2 Global Generic Drugs Price (2015-2020)

6 GLOBAL SORAFENIB MARKET SEGMENT BY APPLICATION

6.1 Global SorafenibSales Market Share by Application (2015-2020)
6.2 Kidney Cancer Sales Growth Rate (2015-2020)
6.3 Liver Cancer Sales Growth Rate (2015-2020)
6.4 Thyroid Cancer Sales Growth Rate (2015-2020)
6.5 Other Sales Growth Rate (2015-2020)

7 GLOBAL SORAFENIB MARKET FORECAST

7.1 Global Sorafenib Sales, Revenue Forecast
  7.1.1 Global Sorafenib Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Sorafenib Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Sorafenib Price and Trend Forecast (2020-2025)
7.2 Global Sorafenib Sales Forecast by Region (2020-2025)
  7.2.1 North America Sorafenib Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Sorafenib Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Sorafenib Production, Revenue Forecast (2020-2025)
  7.2.4 China Sorafenib Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF SORAFENIB INDUSTRY KEY MANUFACTURERS

8.1 Bayer
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Bayer Sorafenib Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Bayer News
8.2 Mylan
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Mylan Sorafenib Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Mylan News
8.3 Natco Pharma
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Natco Pharma Sorafenib Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Natco Pharma News
8.4 Cipla
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Cipla Sorafenib Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Cipla News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Sorafenib Picture
Figure Research Programs/Design for This Report
Figure Global Sorafenib Market by Regions (2019)
Table Global Market Sorafenib Comparison by Regions (M USD) 2019-2025
Table Global Sorafenib Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Sorafenib by Type in 2019
Figure Patented Drugs Picture
Figure Generic Drugs Picture
Table Global Sorafenib Sales by Application (2019-2025)
Figure Global Sorafenib Sales Market Share by Application in 2019
Figure Kidney Cancer Picture
Figure Liver Cancer Picture
Figure Thyroid Cancer Picture
Figure Other Picture
Table Global Sorafenib Sales by Manufacturer (2018-2020)
Figure Global Sorafenib Sales Market Share by Manufacturer in 2019
Table Global Sorafenib Revenue by Manufacturer (2018-2020)
Figure Global Sorafenib Revenue Market Share by Manufacturer in 2019
Table Global Sorafenib Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Sorafenib Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Sorafenib Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Sorafenib Market
Table Key Manufacturers Sorafenib Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sorafenib
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Sorafenib Sales (K Units) by Region (2015-2020)
Table Global Sorafenib Sales Market Share by Region (2015-2019)
Figure Global Sorafenib Sales Market Share by Region (2015-2019)
Figure Global Sorafenib Sales Market Share by Region in 2018
Table Global Sorafenib Revenue (Million US$) by Region (2015-2020)
Table Global Sorafenib Revenue Market Share by Region (2015-2020)
Figure Global Sorafenib Revenue Market Share by Region (2015-2020)
Figure Global Sorafenib Revenue Market Share by Region in 2019
Table Global Sorafenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Sorafenib Sales (K Units) Growth Rate (2015-2020)
Table North America Sorafenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Sorafenib Sales (K Units) Growth Rate (2015-2020)
Table Europe Sorafenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Sorafenib Sales (K Units) Growth Rate (2015-2020)
Table Japan Sorafenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Sorafenib Sales (K Units) Growth Rate (2015-2020)
Table China Sorafenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Sorafenib Sales by Type (2015-2020)
Table Global Sorafenib Sales Market Share by Type (2015-2020)
Figure Global Sorafenib Sales Market Share by Type in 2019
Table Global Sorafenib Revenue by Type (2015-2020)
Table Global Sorafenib Revenue Market Share by Type (2015-2020)
Figure Global Sorafenib Revenue Market Share by Type in 2019
Figure Global Patented Drugs Sales Growth Rate (2015-2020)
Figure Global Patented Drugs Price (2015-2020)
Figure Global Generic Drugs Sales Growth Rate (2015-2020)
Figure Global Generic Drugs Price (2015-2020)
Table Global Sorafenib Sales by Application (2015-2020)
Table Global Sorafenib Sales Market Share by Application (2015-2020)
Figure Global Sorafenib Sales Market Share by Application in 2019
Figure Global Kidney Cancer Sales Growth Rate (2015-2020)
Figure Global Liver Cancer Sales Growth Rate (2015-2020)
Figure Global Thyroid Cancer Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Sorafenib Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Sorafenib Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Sorafenib Price and Trend Forecast (2020-2025)
Table Global Sorafenib Sales (K Units) Forecast by Region (2020-2025)
Figure Global Sorafenib Production Market Share Forecast by Region (2020-2025)
Figure North America Sorafenib Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Sorafenib Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Sorafenib Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Sorafenib Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Sorafenib Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Sorafenib Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Sorafenib Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Sorafenib Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Bayer Company Profile
Figure Sorafenib Product Picture and Specifications of Bayer
Table Sorafenib Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayer Sorafenib Market Share (2018-2020)
Table Bayer Main Business
Table Bayer Recent Development
Table Mylan Company Profile
Figure Sorafenib Product Picture and Specifications of Mylan
Table Sorafenib Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mylan Sorafenib Market Share (2018-2020)
Table Mylan Main Business
Table Mylan Recent Development
Table Natco Pharma Company Profile
Figure Sorafenib Product Picture and Specifications of Natco Pharma
Table Sorafenib Production, Price, Revenue and Gross Margin of 2018-2020
Figure Natco Pharma Sorafenib Market Share (2018-2020)
Table Natco Pharma Main Business
Table Natco Pharma Recent Development
Table Cipla Company Profile
Figure Sorafenib Product Picture and Specifications of Cipla
Table Sorafenib Production, Price, Revenue and Gross Margin of 2018-2020
Figure Cipla Sorafenib Market Share (2018-2020)
Table Cipla Main Business
Table Cipla Recent Development
Table of Appendix